renoprotective effect of fucoidan from seaweed sargassumangustifolium c. agardh 1820 on gentamicin-induced nephrotoxicity:from marine resources to therapeutic uses

Background: nephrotoxicity is a major side effect of aminoglycoside antibiotics, caused by oxidative damage and inflammation.fucoidan, a group of sulfated polysaccharides derived from different species of brown algae, are well recognized for their antioxidant and anti-inflammatory activities.objectives: in the present study, we aimed to investigate, for the first time, the efficacy of fucoidan extracted from sargassum angustifolium c. agardh 1820 against gentamicin-induced nephrotoxicity in rats.methods: twenty-eight male wistar rats were divided into 4 groups of control, gentamicin (100 mg/kg), and gentamicin plus 50-and 100-mg/kg/day fucoidan pretreatment. in the end, all rats were killed, and then urine, blood, and tissue samples were prepared.kidney weight (kw), body weight (bw), and 24-hour urine volume, as well as serum creatinine (cr), blood urea nitrogen (bun), crclearance, and malondialdehyde (mda) levels and superoxide dismutase (sod) activity, were measured. kidney samples were alsoevaluated for histopathological changes.results: gentamicin significantly increased kw, kw/bw ratio, 24-hour urine volume, serum cr, mda, and bun levels; however, fucoidan pretreatment, especially at a dose of 50 mg/kg, significantly returned these variables near to the control group values. gentamicin also decreased bw gain, cr clearance, sod activity, and the degree of renal tissue damage compared to the control group,while treatment with fucoidan significantly reversed these alterations.conclusions: the results show that fucoidan from s. angustifolium c. agardh 1820 ameliorates gentamicin-induced nephrotoxicityby alleviating oxidative stress and augmenting antioxidant enzymes activity in renal tissue, suggesting the potential use of thisfucoidan in a clinical setting.